Labeling substance, immunoassay method, immunoassay reagent, method for measuring analyte, analyte measurement kit, and lateral-flow chromatographic test strip

The use of a metal-resin composite labeling substance with controlled particle diameter CV and three-dimensional metal distribution in immunoassays addresses the challenge of correlating analyte concentration and color intensity, enabling precise and sensitive analyte detection and quantification.

WO2024247900A1PCT designated stage expired Publication Date: 2024-12-05NIPPON STEEL CHEM & MATERIAL CO LTD
View PDF 13 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/019126
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-31
Filing Date
2024-05-24
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current immunoassays face challenges in achieving a sufficient correlation between analyte concentration and color intensity, leading to insufficient precision in quantifying analytes, particularly at low concentrations, due to the limitations of existing labeling substances.

Method used

A labeling substance with a metal-resin composite having a coefficient of variation (CV) of particle diameter of 6% or less, where metal particles are three-dimensionally distributed on resin particles, enhancing the correlation between analyte concentration and color intensity through localized surface plasmon resonance and electronic transition.

Benefits of technology

This approach allows for highly sensitive and precise detection and quantification of analytes, even at low concentrations, with improved durability and visibility without the need for special equipment or additional work processes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024019126_05122024_PF_FP_ABST
    Figure JP2024019126_05122024_PF_FP_ABST
Patent Text Reader

Abstract

This labeling substance comprises a metal-resin composite 100 that has a resin particle 10 and a plurality of metal particles 20 immobilized on the resin particle 10. When the CV value of the particle diameter D1 of the metal-resin composite 100 is 6% or less and the mode for the particle diameter of the metal-resin composite is α [nm], the abundance rate of particles having a particle diameter less than α×0.94 is 10% or less. In an immunoassay, the amount of analyte contained in a sample is quantified on the basis of the localized surface plasmon resonance of the metal-resin composite 100 in the labeling substance and / or a coloring intensity derived from light energy absorption caused by electron transitions.
Need to check novelty before this filing date? Find Prior Art

Description

Labeling substance, immunoassay method, immunoassay reagent, analyte measurement method, analyte measurement kit, and lateral flow chromatography test strip

[0001] The present invention relates to a labeling substance used in, for example, immunoassay, an immunoassay method, an immunoassay reagent, an analyte measurement method, an analyte measurement kit, and a lateral flow chromatography test strip.

[0002] Immunoassays are methods for qualitatively and quantitatively analyzing trace components by utilizing specific reactions between antigens and antibodies. In immunoassays, detection sensitivity is increased by binding a labeling substance to an antibody, an antigen, or a complex of these. Therefore, the labeling ability of a labeling substance can be said to be an important factor that determines the detection ability in immunoassays. It has been proposed to use composite particles, which are composites of metal particles and resin particles, as labeling substances for immunoassays (Patent Documents 1 to 3).

[0003] Patent Document 1 proposes a colored latex consisting of gold nanoparticles bound to the surface of polymer-based latex particles. Patent Documents 2 and 3 propose a metal-resin composite in which a specific proportion of metal particles are present in the surface layer of resin particles, which has excellent durability and visibility and enables highly sensitive determination in immunoassays without requiring any special equipment or additional work steps.

[0004] Proposals have also been made to enable quantification of analytes by immunoassay (Patent Documents 4 to 6). Patent Document 4 discloses a reverse lateral flow immunoassay method designed to detect human antigen-specific immunoglobulin E (IgE). Patent Document 5 discloses a method for determining the amount of an analyte in a sample based on a signal obtained by irradiating a lateral flow strip using highly doped upconversion nanoparticles with a light beam. Patent Document 6 discloses a method for applying a sample to a device including a lateral flow assay (LFA) with a porous matrix and an aqueous two-phase system (ATPS) disposed in the porous matrix, and quantifying the analyte in the LFA. Patent Documents 4 to 6 investigate improving the detection sensitivity of analytes by using ingenious instruments and reagents or special nanoparticles. However, it cannot be said that a sufficient correlation has been obtained between the concentration of the analyte in the sample and the color intensity, and it is considered that this method is insufficient for highly accurate quantification of the analyte.

[0005] Non-Patent Document 1 discloses a microgel in which gold nanoparticles are supported on poly-2-vinylpyridine latex particles, and the pH response of the microgel particle size is confirmed by changes in the behavior of the localized surface plasmon resonance of the gold nanoparticles. However, in this microgel, the gold nanoparticles are supported in a single layer near the surface of the latex particles. Therefore, the amount of gold nanoparticles supported is low, and it is thought that a deep color tone effective for immunoassays cannot be obtained. Furthermore, no investigation has been conducted into the material, structure, composition, etc. of the microgel, and its effectiveness in specific applications such as immunoassay reagents is unknown.

[0006] JP 2009-168495 A International Publication WO2016 / 002742 International Publication WO2017 / 010391 JP 2023-506679 A JP 2022-502637 A Japanese Patent No. 6833519

[0007] K. Akamatsu, M. Shimada, T. Tsuruoka, H. Nawafune, S. Fujii and Y. Nakamura; Langmuir 2010,26,1254-1259.

[0008] An object of the present invention is to provide a labeling substance that provides a sufficient correlation between the concentration of an analyte in a sample and the intensity of color development in an immunoassay, and that enables the analyte to be quantified with high accuracy.

[0009] As a result of intensive research, the present inventors have found that the above-mentioned problems can be solved by controlling the coefficient of variation (CV value) of particle size of a metal-resin composite of a specific structure used as a labeling substance in immunoassays, and have thus completed the present invention.

[0010] That is, the labeled substance of the present invention is a labeled substance comprising a metal-resin composite having resin particles and a plurality of metal particles immobilized on the resin particles. The labeled substance of the present invention has a CV value of particle diameters of the metal-resin composite of 6% or less, and when the mode of particle diameters of the metal-resin composites is α [nm], the proportion of particles having a diameter smaller than α × 0.94 is 10% or less.

[0011] In the labeling substance of the present invention, the metal particles may be particles of platinum or an alloy thereof, or particles of gold or an alloy thereof.

[0012] In the labeling substance of the present invention, the average particle size of the metal-resin composite may be within the range of 50 nm to 1000 nm.

[0013] In the labeling substance of the present invention, at least some of the metal particles may be three-dimensionally distributed in the surface layer portion of the resin particle.

[0014] The labeling substance of the present invention may be used by adsorbing an antigen or antibody onto the surface of the metal-resin complex.

[0015] The immunoassay of the present invention uses the above-mentioned labeling substance.

[0016] The immunoassay reagent of the present invention comprises the above-mentioned labeling substance.

[0017] The method for measuring an analyte of the present invention is a method for detecting or quantifying an analyte contained in a sample. The method for measuring an analyte of the present invention uses a lateral flow chromatography test strip including a membrane and a determination zone in which a capture ligand that specifically binds to the analyte is immobilized on the membrane. The method for measuring an analyte of the present invention includes the following steps (I) to (III): step (I): contacting the analyte contained in the sample with a labeled antibody obtained by labeling an antibody that specifically binds to the analyte with the labeling substance; step (II): contacting the complex containing the analyte and the labeled antibody formed in step (I) with the capture ligand in the determination zone; and step (III): measuring the color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electron transition of the metal-resin complex in the labeling substance.

[0018] The method for measuring an analyte of the present invention may further comprise step (IV): a step of estimating the amount of the analyte contained in the sample based on the measured color intensity.

[0019] The analyte measurement kit of the present invention is an analyte measurement kit for detecting or quantifying an analyte contained in a sample, and comprises: a lateral flow chromatography test strip including a membrane and a determination section in which a capture ligand that specifically binds to the analyte is immobilized on the membrane; and a detection reagent including a labeled antibody in which an antibody that specifically binds to the analyte is labeled with the labeling substance.

[0020] The analyte measurement kit of the present invention may further include a device for measuring the color intensity in the determination part, and the color intensity may be a color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electron transition of the metal-resin complex in the complex of the analyte and the labeled antibody.

[0021] The analyte measurement kit of the present invention may further include reference standard data showing the relationship between the color intensity in the determination zone and the concentration of the analyte, and the color intensity may be a color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electron transition of the metal-resin complex in the complex of the analyte and the labeled antibody.

[0022] The lateral flow chromatography test strip of the present invention is a lateral flow chromatography test strip for detecting or quantifying an analyte contained in a sample, and includes: a membrane; a determination section in which a capture ligand that specifically binds to the analyte is immobilized on the membrane in the direction in which the sample develops; and a reaction section upstream of the determination section that contains a labeled antibody in which an antibody that specifically binds to the analyte is labeled with the labeling substance.

[0023] By using the labeling substance of the present invention, a sufficient correlation can be obtained between the analyte concentration and the color intensity in an immunoassay, enabling highly sensitive detection of the analyte in a sample, and particularly enabling highly accurate quantification of low concentrations of analyte. Furthermore, since the labeling substance of the present invention has a structure in which multiple metal particles are immobilized on resin particles, the metal particles are loaded in large amounts and are less likely to detach from the resin particles. Furthermore, the metal particles exhibit not only localized surface plasmon resonance but also light energy absorption due to electron transition. Therefore, the labeling substance of the present invention is excellent in durability and visibility, and is an excellent material that enables highly sensitive detection of analytes, particularly high-accuracy quantification of low concentrations of analyte, without the need for additional special equipment or work processes, and can be preferably applied to various immunoassays.

[0024] FIG. 1 is a schematic diagram showing the cross-sectional structure of a metal-resin composite used for a labeled substance according to one embodiment of the present invention. FIG. 2 is a schematic diagram showing the cross-sectional structure of one aspect of a metal-resin composite. FIG. 3 is a schematic diagram showing the cross-sectional structure of another aspect of a metal-resin composite. FIG. 4 is an explanatory diagram showing an overview of a method for measuring an analyte using a lateral flow chromatography test strip according to one embodiment of the present invention. FIG. 5 is a cross-sectional view of an immunochromatographic strip prepared in an example. FIG. 6 is a scatter plot of test line color intensity versus CRP antigen concentration in Examples 1 to 3 and Comparative Examples 1 to 3. FIG. 7 is a scatter plot of test line color intensity versus CRP antigen concentration in an antigen concentration range of 0 to 5 ng / ml in Examples 1 to 3 and Comparative Examples 1 to 3.

[0025] Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings.

[0026] [Labeling Substance] The labeling substance of this embodiment comprises a metal-resin composite and is applicable to immunoassays. The metal-resin composite has resin particles and a plurality of metal particles immobilized on the resin particles. The CV value of the particle size of the metal-resin composite is 6% or less. As shown in the Examples below, a strong correlation is obtained between the concentration of an analyte in a sample and the color intensity in immunochromatography when the CV value is 6% or less. As a result, the analyte can be detected with high sensitivity, and highly accurate quantification is possible, especially for low concentrations of analyte. From this perspective, the CV value of the particle size of the metal-resin composite is preferably 5% or less, more preferably 4% or less, even more preferably 3% or less, and most preferably 2% or less.

[0027] FIG. 1 is an example of a cross-sectional schematic diagram of a metal-resin composite. The metal-resin composite 100 includes resin particles 10 and metal particles 20. In the metal-resin composite 100, the metal particles 20 are fixed to the resin particles 10. The resin particles 10 are preferably relatively larger than the metal particles 20. That is, in the metal-resin composite 100, a large number of relatively small metal particles 20 are fixed to the large resin particles 10. In this case, as shown in FIG. 1, the relationship between the particle diameter D1 of the metal-resin composite 100, the particle diameter D2 of the resin particles 10, and the particle diameter D3 of the metal particles 20 is D1>D2>D3. Here, the particle diameter D1 of the metal-resin composite 100 means the maximum diameter based on the metal particles 20 located at the outermost positions in the metal-resin composite 100. That is, the particle diameter D1 of the metal-resin composite 100 is the particle diameter D2 of the resin particle 10 plus the length of the protruding portion of the partially exposed particle 40 or the surface-adsorbed particle 50 described below.

[0028] The average particle diameter of the metal-resin composite 100 (i.e., the average of the particle diameters D1 in FIG. 1) is preferably, for example, 50 to 1000 nm. If the average particle diameter of the metal-resin composite 100 is less than 50 nm, for example, the amount of metal particles 20 supported tends to be smaller, resulting in a tendency for the metal particles 20 to be less colored than metal particles 20 of the same size. If the average particle diameter of the metal-resin composite 100 exceeds 1000 nm, when used as a labeled substance or reagent, the metal-resin composite 100 tends to clog the pores of a chromatographic medium such as a membrane filter, and dispersibility tends to decrease. The average particle diameter of the metal-resin composite 100 is preferably 600 nm, more preferably 500 nm, from the viewpoint of improving dispersibility when used as a labeled substance or reagent and obtaining high detection sensitivity when the metal-resin composite 100 is used in immunoassays. On the other hand, the preferred lower limit is 100 nm, more preferably 200 nm, and even more preferably 300 nm. In particular, when the average particle diameter of the metal-resin composite 100 is 300 nm or more, stable and excellent detection sensitivity can be obtained when the metal-resin composite 100 is used as a labeling substance for immunochromatography. The average particle diameter of the metal-resin composite 100 can be measured by laser diffraction / scattering, dynamic light scattering, or centrifugal sedimentation.

[0029] Furthermore, when the mode of particle diameter (i.e., D1 in FIG. 1 ) detected by a particle size distribution measurement device is α [nm], the metal-resin composite 100 has a particle diameter smaller than α × 0.94, with a proportion of particles having a diameter of 10% or less. This proportion is preferably 5% or less, more preferably 3%, and even more preferably 2% or less. By setting the proportion of metal-resin composites 100 having a particle diameter smaller than α × 0.94 to 10% or less, the light absorption performance per particle of the metal-resin composites 100, which have excellent color development, can be made approximately the same level. As a result, highly sensitive and quantitative color development relative to antigen concentration can be obtained in immunochromatography, which is preferable. Note that, for example, a centrifugal sedimentation particle size distribution measurement device can be used as the particle size distribution measurement device. The mode of particle diameter α is the particle diameter most frequently detected in the particle size distribution of the metal-resin composite 100 measured by the particle size distribution measurement device. Furthermore, α×0.94 is the particle diameter obtained by multiplying α by 0.94 when the mode of particle diameter of the metal-resin composite 100 is α [nm]. Here, the reason for multiplying by 0.94 is that if the particle diameter is too small compared to the mode, the amount of metal supported is small compared to a metal-resin composite whose particle diameter is the mode, and therefore the color intensity is low. If the ratio of particles with such small color intensity is too high, the detection sensitivity decreases. In other words, in order to have high detection sensitivity, it is preferable to have fewer particles with particle diameters smaller than the mode of the particle diameter.

[0030] <Resin Particles> The structure and composition of the resin particles 10 are not limited, but the resin particles 10 are preferably particles of a polymer having a substituent in its structure capable of adsorbing metal ions. Examples of polymers having a substituent in their structure capable of adsorbing metal ions include polymers capable of adsorbing anionic ions and polymers capable of adsorbing cationic ions.

[0031] As a polymer capable of adsorbing anionic ions, nitrogen-containing polymers are particularly preferred. Nitrogen-containing polymers are resins having nitrogen atoms in the main chain or side chain, such as polyamines, polyamides, polypeptides, polyurethanes, polyureas, polyimides, polyimidazoles, polyoxazoles, polypyrroles, and polyanilines. Polyamines such as poly-2-vinylpyridine, poly-3-vinylpyridine, and poly-4-vinylpyridine are preferred. Furthermore, when a nitrogen atom is present in the side chain, a wide range of resins can be used, such as acrylic resins, phenolic resins, and epoxy resins. The nitrogen atoms in the nitrogen-containing polymers are excellent in visibility, and are precursors of metal particles 20 that can easily be immobilized with antigens or antibodies. 6 ] 2- [AuCl 4 ] - In this embodiment, the metal ions adsorbed in the nitrogen-containing polymer are reduced to form metal particles 20, and some of the resulting metal particles 20 become encapsulated particles 30 or partially exposed particles 40. 6 ] 2- When [AuCl 4 ] - When the polymer is used, gold particles are formed. The polymer capable of adsorbing cationic ions is a resin having a carboxylic acid group, a sulfonic acid group, or the like in the main chain or side chain. Specific examples of the polymer capable of adsorbing cationic ions include a carboxylic acid group-containing polymer such as an acrylic acid polymer and a sulfonic acid group-containing polymer such as polystyrene sulfonic acid, and more specifically, polyacrylic acid, vinyl carboxylate, polyvinyl acetate, polyvinyl sulfonic acid, polystyrene sulfonic acid, etc. The polymer capable of adsorbing cationic ions is capable of adsorbing Pt due to the carboxylic acid group, sulfonic acid group, etc. contained therein. 2+ , Au 3+ For example, chemisorbed Pt 2+ , Au 3+is reduced to form metal particles 20 (in this case, platinum particles or gold particles), it is possible to prepare a structure similar to the nitrogen-containing polymer particles.

[0032] Note that examples of polymers other than those having a substituent capable of adsorbing metal ions in their structure include polystyrene, but in this case, it is difficult for metal ions to be adsorbed inside the resin particles 10. As a result, most of the generated metal particles 20 become surface-adsorbed particles 50. As will be described later, the surface-adsorbed particles 50 have a small contact area with the resin particles 10, and therefore the adhesive force between the resin particles 10 and the metal particles 20 is small, and the metal particles 20 tend to detach from the resin particles 10 easily.

[0033] The polymer having a substituent capable of adsorbing metal ions in its structure may be a copolymer with a known polymerizable monomer. Examples of copolymers include random copolymers, block copolymers, alternating copolymers, and copolymers in which polymers are crosslinked. Furthermore, resin particles 10 may be formed by copolymerizing two or more types of monomers, or a monomer may be reacted with functional groups present on the surface of resin particles 10, and the resulting monomer may be used as an active terminal for polymerization and further polymerized. While the copolymerization composition is not limited, it is preferable that the monomer containing the substituent capable of adsorbing metal ions is 10 mol % or more. Polymerizable monomers can be selected without limitation depending on the application of the metal-resin composite 100. For example, polymerizable monomers with surfactant properties can be used to improve the shape and size uniformity and dispersion stability of resin particles 10. Examples of such polymerizable monomers include polyethylene glycol methyl ether methacrylate and polyethylene glycol dimethacrylate.

[0034] Furthermore, the average particle diameter of the resin particles 10 (i.e., the average of the particle diameters D2 in FIG. 1 ) is preferably, for example, 45 to 900 nm. If the average particle diameter of the resin particles 10 is less than 45 nm, the variation in the particle diameter D1 of the metal-resin composite 100 increases, making it difficult to control the CV value to 6% or less. On the other hand, if the average particle diameter of the resin particles 10 exceeds 900 nm, when the metal-resin composite 100 is used as a labeling substance or reagent, the resin particles 10 tend to clog the pores of a chromatographic medium such as a membrane filter, and their dispersibility tends to decrease. From the viewpoint of obtaining high detection sensitivity in immunoassays using labeling substances and enabling particularly high-precision quantification, the preferred upper limit of the average particle diameter of the resin particles 10 is 630 nm, more preferably 540 nm, and even more preferably 450 nm. On the other hand, the preferred lower limit of the resin particles 10 is 90 nm, more preferably 180 nm, and even more preferably 270 nm. Furthermore, in order to control the CV value of the particle diameter D1 of the metal-resin composite 100 to 6% or less, it is preferable to set the CV value of the particle diameter of the resin particles 10 to 5% or less. If the CV value of the particle diameter of the resin particles 10 exceeds 5%, the particle diameter D1 of the metal-resin composite 100 is likely to vary, making it difficult to control the CV value to 6% or less. Therefore, the CV value of the particle diameter of the resin particles 10 is preferably 5% or less, more preferably 4% or less, even more preferably 3% or less, and most preferably 2% or less. The average particle diameter of the resin particles 10 can be measured by laser diffraction / scattering, dynamic light scattering, or centrifugal sedimentation.

[0035] <Metal Particles> In the metal-resin composite 100, the metal particles 20 are preferably particles of platinum or an alloy thereof (hereinafter, sometimes simply referred to as "platinum particles") or particles of gold or an alloy thereof (hereinafter, sometimes simply referred to as "gold particles").

[0036] Platinum-resin composites using platinum particles as the metal particles 20 are less likely to aggregate when bound to ligands such as antibodies, and have extremely excellent dispersibility, compared to metal-resin composites containing particles of other metal species. Platinum particles are also resistant to deterioration such as oxidation and have excellent storage stability. Furthermore, platinum particles exhibit absorption due to localized surface plasmon resonance over a wide wavelength range, for example, from 250 nm to 900 nm, and exhibit a strong color close to black due to the absorption of light energy through electronic transitions. Therefore, using platinum-resin composites as labeling substances can achieve high visibility and enhanced analyte detection sensitivity in immunoassays. The use of platinum particles allows for superior detection sensitivity with a smaller loading compared to particles of other metals. Therefore, assuming the same average particle size, platinum-resin composites exhibit significantly higher detection sensitivity than resin composites containing particles of other metal species. Platinum particles may be composed solely of platinum or may be alloys of platinum and other metals. The platinum alloy refers to an alloy consisting of platinum and a metal species other than platinum, containing 1 wt % or more, preferably 50 wt % or more, and more preferably 60 wt % or more of platinum. Here, the other metal species that form an alloy with platinum are not particularly limited, but are preferably, for example, gold, palladium, silver, nickel, copper, etc., and more preferably gold and palladium, which have excellent storage stability and visibility.

[0037] Compared to metal-resin composites containing particles of other metal species, gold-resin composites using gold particles as metal particles are less likely to aggregate when bound to ligands such as antibodies and exhibit extremely excellent dispersibility. Furthermore, they offer excellent visibility and facilitate the immobilization of antigens or antibodies. In particular, by controlling the particle size and interparticle distance between gold particles, various colors, such as red, purple, and blue, can be produced. Therefore, when using gold-resin composites as labeling substances for immunochromatography, labeling substances of various colors can be obtained. Gold particles may consist solely of gold or may be alloys of gold and other metals. A gold alloy refers to an alloy consisting of gold and metal species other than gold, containing 1% by weight or more, preferably 50% by weight or more, and more preferably 60% by weight or more of gold. Here, the other metal species that form an alloy with gold are not particularly limited, but examples include platinum, palladium, silver, nickel, copper, etc., and platinum and palladium, which have excellent storage stability and visibility, are more preferred.

[0038] Furthermore, the metal particles 20 may contain particles of other metals in addition to platinum or gold particles. Palladium, silver, nickel, and copper are preferred as such metals, from the viewpoint of ease of nano-composite formation of metals and resins. These metals can be used alone or as alloys.

[0039] Furthermore, the average particle diameter of the metal particles 20 measured by scanning electron microscope (SEM) observation (i.e., the average particle diameter D3 in FIG. 1 ) is preferably, for example, 1 to 80 nm in the case of platinum particles. If the average particle diameter of the platinum particles is less than 1 nm or more than 80 nm, localized surface plasmon resonance and light energy absorption due to electronic transition are less likely to occur, and sensitivity tends to decrease. Furthermore, from the viewpoint of obtaining high detection sensitivity as a labeling substance, the upper limit of the average particle diameter of the platinum particles is preferably 50 nm, more preferably 30 nm, even more preferably 20 nm, and most preferably 15 nm. In particular, if the average particle diameter of the platinum particles is 15 nm or less, particularly excellent detection sensitivity can be obtained when the metal-resin composite 100 is used as a labeling substance for immunochromatography. On the other hand, the preferred lower limit of the platinum particles is 2 nm.

[0040] Furthermore, the average particle diameter of the metal particles 20 measured by scanning electron microscope (SEM) observation is preferably, for example, 1 to 80 nm in the case of gold particles. If the average particle diameter of the gold particles is less than 1 nm or more than 80 nm, localized surface plasmon resonance and light energy absorption due to electronic transition are less likely to occur, which tends to reduce sensitivity. Furthermore, from the viewpoint of obtaining high detection sensitivity as a labeling substance, the average particle diameter of the gold particles preferably has an upper limit of 70 nm, more preferably 50 nm. On the other hand, the preferred lower limit for gold particles is 2 nm.

[0041] In order to control the CV value of the particle diameter D1 of the metal-resin composite 100 to 6% or less, it is preferable to set the standard deviation of the particle diameter of the metal particles 20 to 15 nm or less. If the standard deviation of the particle diameter of the metal particles 20 exceeds 15 nm, the particle diameter D1 of the metal-resin composite 100 is likely to vary, making it difficult to control the CV value to 6% or less. Therefore, in the case of platinum particles, the standard deviation of the particle diameter of the metal particles 20 is preferably 5 nm or less, more preferably 3 nm or less, and even more preferably 2 nm or less. Furthermore, in the case of gold particles, the standard deviation of the particle diameter is preferably 14 nm or less, more preferably 13 nm or less, and even more preferably 12 nm or less.

[0042] <State of Presence of Metal Particles> The state of presence of the metal particles 20 in the metal-resin composite 100 is not limited. For example, the metal particles 20 may be two-dimensionally distributed on the surface of the resin particles 10, or the metal particles 20 may be encapsulated within the resin particles 10. Alternatively, a core-shell structure may be formed in which the resin particles 10 form the shell and the metal particles 20 form the core. Alternatively, a portion of the metal particles 20 may be three-dimensionally distributed within the resin particles 10 or in the surface layer 60. In this case, a portion of the three-dimensionally distributed metal particles 20 may be partially exposed to the outside of the resin particles 10, or the remaining portion may be encapsulated within the resin particles 10. Specifically, as shown in FIG. 1, the metal particles 20 preferably include metal particles completely encapsulated within the resin particles 10 (also referred to as "encapsulated particles 30"), and metal particles having a portion embedded within the resin particles 10 and a portion exposed to the outside of the resin particles 10 (also referred to as "partially exposed particles 40"). In addition, metal particles (also referred to as "surface-adsorbed particles 50") adsorbed on the surface of the resin particle 10 may also be present. Here, the "surface layer" refers to a range of 50% of the particle radius in the depth direction from the surface of the resin particle 10, based on the outermost position of the metal-resin composite 100 (i.e., the protruding end of the partially exposed particle 40 or the surface-adsorbed particle 50). Furthermore, "distributed three-dimensionally" means that the metal particles 20 are dispersed not only in the plane direction of the resin particle 10 but also in the depth direction.

[0043] When the metal-resin composite 100 is used as a labeling substance, an antigen, antibody, or blocking agent is immobilized on the surface of the resin particle 10 or on the surface of the partially exposed particle 40 or surface-adsorbed particle 50. In this case, the antigen, antibody, or blocking agent is immobilized on the partially exposed particle 40 and surface-adsorbed particle 50, while it is thought that the antigen, antibody, or blocking agent is not easily immobilized on the encapsulated particle 30. However, since the partially exposed particle 40, surface-adsorbed particle 50, and encapsulated particle 30 all exhibit localized surface plasmon resonance and light energy absorption due to electronic transition, not only the partially exposed particle 40 and surface-adsorbed particle 50, but also the encapsulated particle 30 contributes to improving the visibility of the labeling substance. Furthermore, the partially exposed particle 40 and encapsulated particle 30 have a larger contact area with the resin particle 10 than the surface-adsorbed particle 50, and in addition, due to the anchoring effect and other effects of the embedded state, they have a strong physical adsorption force and are less likely to detach from the resin particle 10. Furthermore, the antigen, antibody, or blocking agent adsorbed to the partially exposed particles 40 or the surface-adsorbed particles 50 is unlikely to be released because it forms a coordinate bond with the metal, which makes it possible to improve the durability and stability of the labeled substance using the metal-resin composite 100.

[0044] In the metal-resin composite 100, the encapsulated particles 30 have their entire surfaces covered with the resin that constitutes the resin particles 10. The partially exposed particles 40 have 5% or more and less than 100% of their surface area covered with the resin that constitutes the resin particles 10, and from the viewpoint of the durability of the labeled substance, the lower limit is preferably 20% or more, more preferably 30% or more of the surface area. The surface-adsorbed particles 50 preferably have more than 0% and less than 5% of their surface area covered with the resin that constitutes the resin particles 10.

[0045] Furthermore, the amount of metal particles 20 (the total of the encapsulated particles 30, the partially exposed particles 40, and the surface-adsorbed particles 50) supported on the metal-resin composite 100 is preferably 5 wt % to 70 wt % relative to the weight of the metal-resin composite 100. Within this range, the metal-resin composite 100 exhibits excellent visibility, visual determination, and detection sensitivity as a labeled substance. If the amount of metal particles 20 supported is less than 5 wt %, the amount of immobilized antibody or antigen tends to decrease, resulting in a decrease in detection sensitivity. The lower limit of the amount of metal particles 20 supported is more preferably 10 wt %, even more preferably 15 wt %, and the upper limit is more preferably 70 wt %, even more preferably 65 wt %. Note that a metal-resin composite 100 having platinum particles or gold particles as the metal particles 20 exhibits excellent visibility, visual determination, and detection sensitivity as a labeled substance, even when supported in a smaller amount than other metal particles.

[0046] Furthermore, it is preferable that 10% to 90% by weight of the metal particles 20 are partially exposed particles 40 and surface-adsorbed particles 50. Within this range, a sufficient amount of antibody or antigen can be immobilized on the metal particles 20, resulting in high sensitivity as a labeling substance. It is more preferable that 20% to 80% by weight of the metal particles 20 are partially exposed particles 40 and surface-adsorbed particles 50, and from the viewpoint of durability of the labeling substance, it is even more preferable that the surface-adsorbed particles 50 account for 20% by weight or less.

[0047] Furthermore, when using the metal-resin composite 100 in immunoassays, in order to obtain excellent detection sensitivity, 60% to 100% by weight, preferably 75% to 100% by weight, and more preferably 85% to 100% by weight of the metal particles 20 should be present in the surface layer 60, and even more preferably within 40% of the particle radius in the depth direction from the surface of the resin particle 10. Furthermore, it is preferable that 5% to 90% by weight of the metal particles 20 present in the surface layer 60 are partially exposed particles 40 or surface-adsorbed particles 50, as this ensures a sufficient amount of antibody or antigen immobilized on the metal particles 20, thereby increasing the sensitivity as a labeling substance. In other words, it is preferable that 10% to 95% by weight of the metal particles 20 present in the surface layer 60 are encapsulated particles 30.

[0048] As described above, the encapsulated particles 30 also exhibit light energy absorption due to electronic transition in addition to localized surface plasmon resonance. Therefore, not only the partially exposed particles 40 and the surface-adsorbed particles 50, but also the encapsulated particles 30 contribute to improving the visibility of the labeled substance. From the viewpoint of such improved visibility, it is preferable that the encapsulated particles 30 are concentrated and distributed within a certain range from the surface of the resin particle 10 in the depth direction, as shown in FIG. 2A , for example, in the metal-resin composite 100, and that no encapsulated particles 30 are present near the center of the resin particle 10. More specifically, in order to effectively exhibit light energy absorption due to electronic transition in addition to localized surface plasmon resonance by the encapsulated particles 30, for example, when the particle diameter D2 of the resin particle 10 is 800 nm, 70% by weight or more, preferably 80% by weight or more, and more preferably 90 to 100% by weight of the encapsulated particles 30 are present within a range of, for example, 0 to 200 nm from the surface of the resin particle 10 in the depth direction. In particular, it is preferable that the region where all of the encapsulated particles 30 (100% by weight) are distributed (encapsulated particle distribution region) is within a range of, for example, 0 to 100 nm from the surface of the resin particle 10, because this maximizes the occurrence of light energy absorption due to electronic transition in addition to localized surface plasmon resonance due to the encapsulated particles 30.

[0049] Furthermore, the metal-resin composite 100 may not have encapsulated particles 30. For example, as shown in FIG. 2B , in the metal-resin composite 100, all of the metal particles 20 may be fixed to the surface of the resin particle 10 without overlapping with each other in the radial direction of the resin particle 10. In this case, the metal particles 20 are composed of partially exposed particles 40 and / or surface-adsorbed particles 50.

[0050] [Method for Manufacturing Metal-Resin Composite] There are no particular limitations on the method for manufacturing the metal-resin composite 100. For example, a solution containing metal ions is added to a dispersion of resin particles 10 manufactured by emulsion polymerization, causing the metal ions to be adsorbed onto the resin particles 10 (hereinafter referred to as "metal ion-adsorbed resin particles"). Furthermore, by adding the metal ion-adsorbed resin particles to a reducing agent solution, the metal ions are reduced to generate metal particles 20, and the metal-resin composite 100 can be obtained.

[0051] When platinum particles are generated as the metal particles 20, the solution containing platinum ions is, for example, chloroplatinic acid (H 2 PtCl 6 ) aqueous solution, platinum chloride (PtCl 2 ) solution, etc. In addition, a platinum complex may be used instead of platinum ions. In addition, when gold particles are generated as the metal particles 20, an example of a solution containing gold ions is chloroauric acid (HAuCl 4 ) aqueous solutions, etc. Furthermore, gold complexes may be used instead of gold ions. Furthermore, instead of water, hydrous alcohols or alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, and t-butanol, and acids such as hydrochloric acid, sulfuric acid, and nitric acid may be used as the solvent for the solution containing metal ions. Furthermore, additives such as water-soluble polymers such as polyvinyl alcohol, surfactants, alcohols; ethers such as tetrahydrofuran, diethyl ether, and diisopropyl ether; polyols such as alkylene glycol, polyalkylene glycol, monoalkyl ethers or dialkyl ethers thereof, and glycerin; and various water-miscible organic solvents such as ketones such as acetone and methyl ethyl ketone may be added to the solution as needed. Such additives accelerate the reduction reaction rate of the metal ions and are effective in controlling the size of the generated metal particles 20.

[0052] Known reducing agents can be used. Examples include sodium borohydride, dimethylamine borane, citric acid, sodium hypophosphite, hydrazine hydrate, hydrazine hydrochloride, hydrazine sulfate, formaldehyde, sucrose, glucose, ascorbic acid, erythorbic acid, sodium phosphinate, hydroquinone, and Rochelle salt. Among these, sodium borohydride, dimethylamine borane, and citric acid are preferred. A surfactant can be added to the reducing agent solution, or the pH of the solution can be adjusted, as needed. pH adjustment can be performed using a buffer such as boric acid or phosphoric acid, an acid such as hydrochloric acid or sulfuric acid, or an alkali such as sodium hydroxide or potassium hydroxide. Furthermore, the particle size of the metal particles 20 formed can be controlled by adjusting the reduction rate of the metal ions through the temperature of the reducing agent solution.

[0053] Furthermore, when reducing the metal ions in the metal ion-adsorbing resin particles to generate metal particles 20, the metal ion-adsorbing resin particles may be added to a reducing agent solution, or the reducing agent may be added to the metal ion-adsorbing resin particles.

[0054] Furthermore, in order to maintain the dispersibility of the metal-resin composite 100 in water, a dispersant such as citric acid, poly-L-lysine, polyvinylpyrrolidone, polyvinylpyridine, polyvinyl alcohol, DISPERBYK194, DISPERBYK180, or DISPERBYK184 (manufactured by BIGChemie Japan) may be added. Furthermore, the dispersibility can be maintained by adjusting the pH with a buffer such as boric acid or phosphoric acid, an acid such as hydrochloric acid or sulfuric acid, or an alkali such as sodium hydroxide or potassium hydroxide.

[0055] Depending on the manufacturing conditions of the metal-resin composite 100, the particle diameter D1 of the metal-resin composite 100 may vary, resulting in a large CV value exceeding 6%. In such cases, highly sensitive detection, particularly highly accurate quantification, becomes difficult. In order to control the CV value of the particle diameter D1 of the metal-resin composite 100 to 6% or less, it is preferable to first uniformize the particle diameter D2 of the resin particles 10. To achieve this, when emulsion-polymerizing the resin particles 10, it is important to thoroughly mix and homogenize the reaction solution containing the raw material monomers, surfactant, polymerization catalyst, etc. For example, it is preferable to thoroughly stir the reaction solution containing the raw material monomers, surfactant, polymerization catalyst, etc. before adding the polymerization initiator. The stirring speed varies depending on the reaction scale. For example, when a 500 ml round vessel is used and an imperfect semicircular (circle cut at a point other than the center) plate-shaped stirring blade [width (length of cut edge): 8 cm, vertical width: 1.6 cm, thickness: 0.3 cm; hereinafter simply referred to as "imperfect semicircular stirring blade"] is attached so that its longitudinal direction is perpendicular to the central axis of the round vessel, the stirring speed is preferably 30 to 500 rpm, preferably 50 to 300 rpm, and more preferably 100 to 200 rpm, and is preferably constant. A stirring speed lower than 30 rpm results in an uneven dispersion of the raw material monomers, while a speed higher than 500 rpm results in turbulence in the flow of the reaction solution. In either case, the particle diameter D2 of the resin particles 10 becomes uneven. In this case, the stirring temperature and stirring time are also important in achieving a uniform particle diameter D2 of the resin particles 10. Therefore, the stirring is preferably carried out while gradually changing the temperature and time, for example, between room temperature and approximately 70°C. More specifically, in the process of increasing the temperature of the reaction solution, it is advisable to thoroughly stir the solution for approximately 20 to 60 minutes in each temperature range, for example, at approximately 25 to 35° C. and at approximately 55 to 65° C. The combination of the reaction vessel and the stirrer can be appropriately selected so as to achieve the same stirring efficiency as above.

[0056] Furthermore, after adding the polymerization initiator to the reaction solution, it is preferable to thoroughly stir the reaction solution, for example, at a temperature range of around 55 to 65°C. The stirring speed, which depends on the reaction scale, is 30 to 500 rpm, preferably 50 to 300 rpm, and more preferably 100 to 200 rpm when using, for example, a 500 milliliter round vessel and stirring with an incomplete semicircular stirring blade. In this case, too, a stirring speed below 30 rpm results in an uneven dispersion of the raw material monomers, while a speed exceeding 500 rpm causes turbulence in the flow of the reaction solution. In either case, the particle diameter D2 of the resin particles 10 becomes uneven. The stirring time is, for example, about 1 to 5 hours, preferably about 2 to 4 hours. The combination of the reaction vessel and the stirrer can be appropriately selected to achieve the same stirring efficiency as described above.

[0057] Furthermore, in order to control the CV value of the particle diameter D1 of the metal-resin composite 100 to 6% or less, it is also important to thoroughly mix and homogenize the resin particle dispersion containing the resin particles 10 and the metal compound. The resin particle dispersion, while depending on the reaction scale, should be thoroughly stirred at a speed of 30 to 500 rpm, preferably 50 to 300 rpm, and more preferably 100 to 200 rpm when using a 500 milliliter round container and stirring with an incomplete semicircular stirring blade, and it is preferable that the stirring speed be constant. Furthermore, the stirring temperature and stirring time of the resin particle dispersion are also important in regulating the particle diameter D1 of the metal-resin composite 100. Therefore, it is preferable to carry out stirring for, for example, about 1 to 5 hours, preferably about 2 to 4 hours, at a temperature range of about room temperature to about 40°C, preferably about 25 to 35°C. By sufficiently homogenizing the resin particle dispersion before adding the reducing agent, the metal ions are uniformly adsorbed onto the resin particles 10, which makes it possible to reduce the standard deviation of the particle diameter of the metal particles 20, and as a result, it becomes easy to control the CV value of the particle diameter D1 of the metal-resin composite 100 to 6% or less. The combination of the reaction vessel and the stirrer can be appropriately selected so as to achieve the same stirring efficiency as above.

[0058] Furthermore, in order to control the CV value of the particle diameter D1 of the metal-resin composite 100 to 6% or less, it is preferable to thoroughly stir the mixed solution (reduction reaction solution) of the resin particle dispersion and the reducing agent in the reduction step. The stirring speed depends on the reaction scale. For example, when using a 500 milliliter round container and stirring with an incomplete semicircular stirring blade, stirring is preferably performed at a speed of 30 to 500 rpm, preferably 50 to 300 rpm, and more preferably 100 to 200 rpm, and it is preferable that the stirring speed be constant. In this case, the stirring temperature and stirring time are also important in ensuring a uniform particle diameter D1 of the metal-resin composite 100. For example, in the process of raising the temperature of the reaction solution from a state cooled to around 0°C to near room temperature, sufficient stirring is preferably performed for about 30 to 120 minutes in a temperature range of about 0 to 5°C, or for about 1 to 3 hours in a temperature range of about 25 to 30°C. By sufficiently homogenizing the reduction reaction solution, it is possible to reduce the standard deviation of the particle diameter of the metal particles 20, and as a result, it becomes easy to control the CV value of the particle diameter D1 of the metal-resin composite 100 to 6% or less. The combination of the reaction vessel and the stirrer can be appropriately selected so as to achieve the same stirring efficiency as above.

[0059] The metal-resin composite 100 obtained as described above can be preferably used as a labeled substance in various immunoassays, particularly by adsorbing an antigen or antibody onto the surface of the metal particles 20. Furthermore, since the CV value of the particle diameter D1 of the metal-resin composite 100 is controlled to 6% or less, the composite not only has excellent visual determination in the low concentration range (high sensitivity range), but also can be preferably used as a labeled substance or an immunoassay reagent containing the labeled substance, which allows quantitative analysis of low concentrations of analytes using a measuring device such as an immunochromatography reader. Furthermore, the form of the labeled substance and the immunoassay reagent is not particularly limited, and the metal-resin composite 100 can be used, for example, as a dispersion in which the metal-resin composite 100 is dispersed in water or a pH-adjusted buffer solution.

[0060] The method for adsorbing the antigen or antibody onto the surface of the metal particles 20 is not particularly limited, and known physical adsorption and chemical adsorption methods can be used. Chemical adsorption is preferred because it strengthens the bond between the metal particles 20 and the antigen or antibody. Physical adsorption and chemical adsorption may be used in combination.

[0061] Examples of physical adsorption include a method of immersing the metal-resin composite 100 in a buffer solution containing an antigen or antibody and incubating it, and a method of immersing the metal-resin composite 100 in a buffer solution and then adding an antigen or antibody.

[0062] Examples of chemical adsorption include a method of introducing an SH group into an antigen or antibody and reacting it with the metal-resin composite 100 to form a metal-SH bond, and a method of introducing a carboxyl group onto the surface of the metal-resin composite 100, followed by succinimidylation and reaction with the amino group of the antigen or antibody to form a chemical bond. Compounds suitable for introducing a carboxyl group onto the surface of the metal-resin composite 100 include compounds having both a carboxyl group and a functional group capable of coordinating with the metal, such as an amino group, an SH group, a carbonyl group, an amide group, or an imide group. Because of their strong coordinate bond with the metal, an SH group is preferred as the functional group. Examples of compounds having an SH group and a carboxyl group at both ends include mercaptopropionic acid, mercaptoundecanoic acid, and mercaptolauric acid. Furthermore, polymeric compounds having multiple carboxyl groups and functional groups capable of coordinating with the metal within a single molecule are more likely to form a stable bond with the metal-resin composite 100. For example, polyglutamic acid and polyaspartic acid, which are polypeptides of glutamic acid and aspartic acid, are more preferable as polymer compounds for introducing carboxyl groups onto the surface of the metal-resin composite 100 .

[0063] Next, a method for measuring an analyte using the metal-resin composite 100 as a labeling substance, a test strip for lateral flow chromatography, and an analyte detection and quantification kit will be described.

[0064] [Lateral flow chromatography test strip] First, a lateral flow chromatography test strip (hereinafter, sometimes simply referred to as a "test strip") according to one embodiment of the present invention will be described with reference to Figure 3. This test strip 200 is preferably usable in the analyte measurement method according to one embodiment of the present invention, as will be described later.

[0065] The test strip 200 includes a membrane 110. The membrane 110 is provided with a sample application section 120, a determination section 130, and a liquid absorption section 140, which are arranged in this order in the direction in which the sample develops.

[0066] <Membrane> The membrane 110 used in the test strip 200 can be made of materials commonly used as membranes in general test strips. The membrane 110 is formed of an inert material (a material that does not react with the analyte 160, various ligands, etc.) that exhibits capillary action and is made of a microporous material that allows the sample to develop upon application. Specific examples of the membrane 110 include fibrous or nonwoven fibrous matrices made of polyurethane, polyester, polyethylene, polyvinyl chloride, polyvinylidene fluoride, nylon, cellulose derivatives, etc., membranes, filter paper, glass fiber filter paper, cloth, cotton, etc. Among these, membranes, filter paper, glass fiber filter paper, etc. made of cellulose derivatives or nylon are preferred, and nitrocellulose membranes, mixed nitrocellulose ester (a mixture of nitrocellulose and cellulose acetate) membranes, nylon membranes, and filter paper are more preferred.

[0067] For easier handling, test strip 200 preferably includes a support for supporting membrane 110. The support may be made of, for example, plastic.

[0068] <Sample Addition Section> The test strip 200 may have a sample addition section 120 for adding a sample containing an analyte 160. The sample addition section 120 is a site for receiving the sample containing the analyte 160 in the test strip 200. The sample addition section 120 may be formed on the membrane 110 upstream of the determination section 130 in the direction in which the sample develops, or the sample addition section 120 may be formed by providing a sample addition pad made of a material such as cellulose filter paper, glass fiber, polyurethane, polyacetate, cellulose acetate, nylon, or cotton cloth on the membrane 110.

[0069] <Determination Unit> A capture ligand 131 that specifically binds to the analyte 160 is immobilized on the determination unit 130. Any capture ligand 131 can be used without particular limitation as long as it forms a specific bond with the analyte 160, and for example, an antibody against the analyte 160 can be preferably used. The capture ligand 131 is immobilized so that it does not move from the determination unit 130 even when a sample is provided to the test strip 200. The capture ligand 131 may be immobilized directly or indirectly to the membrane 110 by physical or chemical bonding, adsorption, or the like.

[0070] The determination unit 130 is not particularly limited as long as it has a configuration that allows the complex 170 containing the labeled antibody 150 and the analyte 160 to come into contact with the capture ligand 131 that specifically binds to the analyte 160. For example, the capture ligand 131 may be immobilized directly on the membrane 110, or the capture ligand 131 may be immobilized on a pad made of cellulose filter paper, glass fiber, nonwoven fabric, or the like that is immobilized on the membrane 110.

[0071] <Liquid-Absorbing Section> The liquid-absorbing section 140 is formed by a pad of a water-absorbent material such as cellulose filter paper, nonwoven fabric, cloth, or cellulose acetate. The speed at which the development front of the added sample moves after it reaches the liquid-absorbing section 140 varies depending on the material and size of the liquid-absorbing section 140. Therefore, by selecting the material, size, etc. of the liquid-absorbing section 140, it is possible to set an optimal speed for detecting and quantifying the analyte 160. The liquid-absorbing section 140 is an optional configuration and may be omitted.

[0072] Test strip 200 may further include any desired portions such as a reaction portion and a control portion, as needed.

[0073] <Reaction Unit> Although not shown, the test strip 200 may have a reaction unit containing a labeled antibody 150 formed on the membrane 110. The reaction unit may be located upstream of the determination unit 130 in the direction of sample flow. The sample addition unit 120 in FIG. 3 may also be used as the reaction unit. When the test strip 200 has a reaction unit, when a sample containing an analyte 160 is supplied to the reaction unit or sample addition unit 120, the analyte 160 contained in the sample can be brought into contact with the labeled antibody 150 in the reaction unit. In this case, simply supplying the sample to the reaction unit or sample addition unit 120 can form a complex 170 containing the analyte 160 and the labeled antibody 150, thereby enabling so-called one-step immunochromatography.

[0074] The reaction area is not particularly limited as long as it contains labeled antibody 150 that specifically binds to analyte 160, but may be formed by directly applying labeled antibody 150 to membrane 110. Alternatively, the reaction area may be formed by immobilizing a pad (conjugate pad) made of, for example, cellulose filter paper, glass fiber, nonwoven fabric, or the like, impregnated with labeled antibody 150, on membrane 110.

[0075] <Control Section> Although not shown, the test strip 200 may have a control section formed on the membrane 110 downstream of the determination section 130 in the direction of sample development, where a capture ligand that specifically binds to the labeled antibody 150 is immobilized. By measuring the color intensity in the control section as well as the determination section 130, it is possible to confirm that the sample provided to the test strip 200 developed and reached the reaction section and the determination section 130, and that the test was performed normally. The control section can be fabricated in the same manner as the above-described determination section 130 and can have the same configuration, except that the capture ligand 131 is replaced with a different type of capture ligand that specifically binds to the labeled antibody 150.

[0076] [Method for Measuring Analyte] Next, a method for measuring analyte 160 using test strip 200 according to one embodiment of the present invention will be described.

[0077] The method for measuring analyte 160 according to this embodiment is a method for detecting or quantifying analyte 160 contained in a sample. The method for measuring analyte 160 according to this embodiment uses a test strip 200 including a membrane 110 and a determination part 130 having a capture ligand 131 that specifically binds to analyte 160 immobilized on the membrane 110. The method for measuring analyte 160 of this embodiment can include the following steps (I) to (III): step (I): contacting analyte 160 contained in a sample with labeled antibody 150, which is an antibody that specifically binds to analyte 160 and is labeled with a labeling substance containing metal-resin composite 100; step (II): contacting complex 170 containing analyte 160 and labeled antibody 150 formed in step (I) with capture ligand 131 in determination unit 130; and step (III): measuring the color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electron transition of metal-resin composite 100 in the labeling substance. Furthermore, the method for measuring analyte 160 of this embodiment can include, as an optional step, step (IV): estimating the amount of analyte contained in the sample based on the measured color intensity.

[0078] Step (I): Step (I) is a step of contacting the analyte 160 contained in the sample with the labeled antibody 150. The manner of contact is not particularly limited as long as a complex 170 containing the analyte 160 and the labeled antibody 150 is formed. For example, the sample may be provided to the sample application section 120 or a reaction section (not shown) of the test strip 200, and the analyte 160 may be contacted with the labeled antibody 150 in the sample application section 120 or the reaction section, or the analyte 160 in the sample may be contacted with the labeled antibody 150 before the sample is provided to the test strip 200.

[0079] The complex 170 formed in step (I) develops and moves on the test strip 200 and reaches the determination section 130 .

[0080] Step (II): In step (II), the complex 170 containing the analyte 160 and the labeled antibody 150 formed in step (I) is brought into contact with the capture ligand 131 in the determination zone 130 of the test strip 200. When the complex 170 is brought into contact with the capture ligand 131, the capture ligand 131 specifically binds to the analyte 160 of the complex 170. As a result, the complex 170 is captured in the determination zone 130.

[0081] Note that because the capture ligand 131 does not specifically bind to the labeled antibody 150, when the labeled antibody 150 that is unbound to the analyte 160 reaches the determination zone 130, the unbound labeled antibody 150 passes through the determination zone 130. If the test strip 200 has a control zone (not shown) to which another capture ligand that specifically binds to the labeled antibody 150 is immobilized, the labeled antibody 150 that has passed through the determination zone 130 continues to develop and binds to the other capture ligand in the control zone. As a result, the labeled antibody 150 that has not formed a complex 170 with the analyte 160 is captured in the control zone.

[0082] After step (II), and before step (III), if necessary, a washing step may be performed to wash the test strip 200 with a buffer solution commonly used in biochemical tests, such as water, physiological saline, or phosphate buffer solution. The washing step can remove labeled antibodies 150 that have not been captured in the determination zone 130 or in the determination zone 130 and control zone (labeled antibodies 150 that have not bound to the analyte 160 and have not formed complexes 170).

[0083] By carrying out the washing step, when measuring color development due to light energy absorption caused by localized surface plasmon resonance and / or electron transition of the metal-resin composite 100 in the determination section 130, or in the determination section 130 and the control section, in step (III), the background color development intensity can be reduced, the signal / background ratio can be increased, and detection sensitivity and quantitation can be further improved.

[0084] Step (III): Step (III) is a step of measuring the color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electron transition of the metal-resin composite 100. After performing step (II) or, if necessary, a washing step, the color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electron transition of the metal-resin composite 100 is measured in the determination unit 130 of the test strip 200, thereby enabling highly sensitive detection of the analyte 160 contained in the sample. The color intensity can be measured using a measuring device such as an immunochromatography reader. The principle of measurement of the color intensity in the measuring device is not particularly limited. For example, an immunochromatography reader irradiates the determination unit 130 with light and measures the color intensity from the attenuation of the reflected light.

[0085] If a control section is formed on the test strip 200, the labeled antibody 150 is captured by another capture ligand in the control section in step (II), forming a complex. Therefore, in step (III), color development due to light energy absorption by localized surface plasmon resonance and / or electron transition can be caused not only in the determination section 130 but also in the control section of the test strip 200. In this way, by measuring the color development intensity in both the determination section 130 and the control section, it is possible to confirm whether the sample provided to the test strip 200 has developed normally and reached the reaction section and the determination section 130.

[0086] Step (IV) is a quantification step in which the amount of analyte 160 contained in the sample is estimated based on the measured color intensity. In this step, reference standard data showing the relationship between the color intensity in the determination unit 130 and the amount of analyte 160 can be used. Examples of reference standard data include a calibration curve, table, or formula showing the relationship between color intensity and analyte concentration. The reference standard data may be prepared for general use, or may be prepared by conducting a preliminary experiment using a standard reagent with a known analyte concentration prior to immunoassay. The labeled substance of this embodiment has a CV value of 6% or less for the particle diameter D1 of the metal-resin composite 100, thereby exhibiting a high correlation between color intensity and analyte concentration. Specifically, a calibration curve showing the relationship between color intensity and analyte concentration exhibits a strong correlation even in the low-concentration range, with a correlation coefficient of 0.90 or greater, preferably 0.95 or greater. This enables not only highly sensitive detection of analyte 160 but also highly accurate quantification.

[0087] <Sample and Analyte> The sample used in the analyte measurement method of this embodiment is not particularly limited as long as it contains a substance that can serve as an antigen, such as a protein, as the analyte 160. Examples include biological samples containing the target analyte 160 (i.e., whole blood, serum, plasma, urine, saliva, sputum, nasal or pharyngeal swabs, cerebrospinal fluid, amniotic fluid, nipple secretions, tears, sweat, skin exudates, tissue, cell, and fecal extracts, etc.), food extracts, etc. If necessary, the analyte 160 contained in the sample may be pretreated prior to step (I) to facilitate the specific binding reaction between the labeled antibody 150 and the capture ligand 131 and the analyte 160. Examples of pretreatment include chemical treatment using various chemicals such as acids, bases, and surfactants, and physical treatment using heating, stirring, ultrasound, etc. In particular, when the analyte 160 is a substance that is not normally exposed on the surface, such as influenza virus NP antigen, treatment with a surfactant or the like is preferable. As the surfactant used for this purpose, a non-ionic surfactant can be used in consideration of the binding reactivity between the capture ligand 131 and the analyte 160, such as a specific binding reaction, for example, an antigen-antibody reaction.

[0088] The sample may be diluted appropriately with a solvent (water, physiological saline, buffer solution, etc.) or a water-miscible organic solvent used in a typical immunological analysis method.

[0089] The analyte 160 is not particularly limited and may be any known analyte, including those with strong anionic properties, those with strong cationic properties, and other analytes. The analyte 160 is not particularly limited as long as it specifically binds to the labeled antibody 150 and the capture ligand 131, and examples thereof include tumor markers, signal transduction substances, proteins such as hormones (including polypeptides, oligopeptides, etc.), nucleic acids (including single-stranded or double-stranded DNA, RNA, polynucleotides, oligonucleotides, PNA (peptide nucleic acid), etc.) or substances having nucleic acids, sugars (including oligosaccharides, polysaccharides, sugar chains, etc.) or substances having sugar chains, lipids, and other molecules. More specifically, examples of analytes include carcinoembryonic antigen (CEA), HER2 protein, prostate-specific antigen (PSA), CA19-9, α-fetoprotein (AFP), immunosuppressant acidic protein (IAP), CA15-3, CA125, estrogen receptor, progesterone receptor, fecal occult blood, troponin I, troponin T, CK-MB, CRP, human chorionic gonadotropin (HCG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), syphilis antibody, influenza virus human hemoglobin, chlamydia antigen, group A beta-hemolytic streptococcal antigen, HBs antibody, HBs antigen, rotavirus, adenovirus, albumin, glycated albumin, etc. Among these, antigens that can be solubilized by nonionic surfactants are preferred, and antigens that form self-aggregates such as viral nucleoproteins are more preferred.

[0090] <Labeled Antibody> In step (I), the labeled antibody 150 is brought into contact with an analyte 160 contained in a sample to form a complex 170 containing the analyte 160 and the labeled antibody 150. The labeled antibody 150 is an antibody that specifically binds to the analyte 160, labeled with a metal-resin composite 100 having a structure in which a plurality of metal particles 20 are immobilized on a resin particle 10. Here, "labeling" means that the metal-resin composite 100 is immobilized to the antibody directly or indirectly by chemical or physical bonding, adsorption, or the like, to the extent that the metal-resin composite 100 does not detach from the labeled antibody 150 in steps (I) to (III). For example, the labeled antibody 150 may be one in which the metal-resin composite 100 is directly bound to the antibody, or one in which the antibody and the metal-resin composite 100 are bound via an arbitrary linker molecule, or one in which each is immobilized on an insoluble particle.

[0091] In the present embodiment, the "antibody" is not particularly limited and known antibodies can be used, including those with strong anionic properties, those with strong cationic properties, and other antibodies. For example, polyclonal antibodies, monoclonal antibodies, antibodies obtained by genetic recombination, and antibody fragments having the ability to bind to antigens [for example, H chains, L chains, Fab, F(ab')], etc. 2 etc.] can be used. Furthermore, the immunoglobulin may be any of IgG, IgM, IgA, IgE, and IgD. Antibody-producing animal species may include humans as well as non-human animals (e.g., mice, rats, rabbits, goats, horses, etc.). Specific examples of antibodies include anti-PSA antibodies, anti-AFP antibodies, anti-CEA antibodies, anti-adenovirus antibodies, anti-influenza virus antibodies, anti-HCV antibodies, anti-IgG antibodies, and anti-human IgE antibodies.

[0092] <Preferred Method for Producing Labeled Antibody> Next, a preferred method for producing labeled antibody 150 will be described. The production of labeled antibody 150 includes at least the following step A: step A) mixing metal-resin composite 100 with an antibody under a first pH condition to allow binding, thereby obtaining labeled antibody 150, and preferably further includes step B: step B) treating labeled antibody 150 under a second pH condition.

[0093] [Step A] In step A, the metal-resin composite 100 is mixed with an antibody under a first pH condition to obtain a labeled antibody 150. In step A, it is preferable to bring the solid metal-resin composite 100, dispersed in a liquid phase, into contact with the antibody.

[0094] The first pH condition is preferably a condition in the range of pH 2 to 10, more preferably, for example, a range of pH 5 to 9, from the viewpoint of uniformly contacting the metal-resin composite 100 with the antibody while maintaining dispersion of the metal-resin composite 100 and activity of the antibody. If the conditions for binding the metal-resin composite 100 with the antibody are less than pH 2, the antibody may be altered and inactivated due to strong acidity, and if the pH exceeds 10, the metal-resin composite 100 and the antibody will aggregate when mixed, making dispersion difficult. However, if the antibody is not inactivated by strong acidity, treatment is possible even at a pH of less than 2.

[0095] Step A is preferably carried out in a binding buffer adjusted to the first pH condition. For example, a predetermined amount of metal-resin composite 100 is mixed with the binding buffer adjusted to the above pH and thoroughly mixed. For example, a boric acid solution adjusted to a predetermined concentration can be used as the binding buffer. The pH of the binding buffer can be adjusted using, for example, hydrochloric acid, sodium hydroxide, or the like.

[0096] Next, a predetermined amount of antibody is added to the resulting mixture, and the mixture is thoroughly stirred and mixed to obtain a labeled antibody-containing solution. From the labeled antibody-containing solution thus obtained, only the labeled antibody 150 can be separated as a solid portion by solid-liquid separation means such as centrifugation.

[0097] [Step B] In step B, the labeled antibody 150 obtained in step A is treated under second pH conditions to perform blocking, which suppresses nonspecific adsorption to the labeled antibody 150. In this case, the labeled antibody 150, which has been separated by solid-liquid separation means, is dispersed in a liquid phase under the second pH conditions.

[0098] The second pH condition is preferably, for example, in the range of pH 2 to 10 from the viewpoint of maintaining antibody activity and suppressing aggregation of labeled antibody 150, and more preferably in the range of pH 5 to 9 from the viewpoint of suppressing nonspecific adsorption of labeled antibody 150. If the blocking condition is below pH 2, the antibody may be denatured and inactivated due to strong acidity, and if the pH exceeds 10, labeled antibody 150 will aggregate, making dispersion difficult.

[0099] Step B is preferably performed using a blocking buffer in which the blocking agent is adjusted to a second pH condition. For example, a blocking buffer adjusted to the above pH is added to a predetermined amount of labeled antibody 150, and the labeled antibody 150 is uniformly dispersed in the blocking buffer. For example, a solution of a protein that does not bind to the analyte is preferably used as the blocking buffer. There are no particular limitations on the blocking agent that can be used in the blocking buffer, and known blocking agents can be used, including those with strong anionic properties, strong cationic properties, and other agents. Examples of proteins include bovine serum albumin, ovalbumin, casein, gelatin, and whey. More specifically, a bovine serum albumin solution adjusted to a predetermined concentration is preferably used. The pH of the blocking buffer can be adjusted using, for example, hydrochloric acid, sodium hydroxide, or the like. Dispersion means such as ultrasonication are preferably used to disperse the labeled antibody 150. In this manner, a dispersion in which the labeled antibody 150 is uniformly dispersed is obtained.

[0100] In the above steps A and B, the metal-resin composite 100 is resistant to aggregation due to pH and can be treated over a wide range of pH, from acidic to alkaline. Therefore, the metal-resin composite 100 used in the present invention has the advantage of being less subject to restrictions on the conditions for producing the labeled antibody 150.

[0101] In this manner, a dispersion of the labeled antibody 150 is obtained. From this dispersion, the labeled antibody 150 alone can be separated as a solid portion by solid-liquid separation means such as centrifugation. Furthermore, if necessary, washing treatment, preservation treatment, etc. can be carried out. The washing treatment and preservation treatment will be described below.

[0102] (Washing Treatment) In the washing treatment, a washing buffer solution is added to the labeled antibody 150 separated by the solid-liquid separation means, and the labeled antibody 150 is uniformly dispersed in the washing buffer solution. For dispersion, it is preferable to use a dispersing means such as ultrasonic treatment. The washing buffer solution is not particularly limited, but for example, a Tris buffer solution, a glycinamide buffer solution, an arginine buffer solution, or the like, adjusted to a predetermined concentration within the pH range of 8 to 9, can be used. The pH of the washing buffer solution can be adjusted using, for example, hydrochloric acid, sodium hydroxide, or the like. The washing treatment of the labeled antibody 150 can be repeated multiple times as necessary.

[0103] (Preservation Treatment) In the preservation treatment, a preservation buffer solution is added to the labeled antibody 150 separated by solid-liquid separation means, and the labeled antibody 150 is uniformly dispersed in the preservation buffer solution. Dispersion is preferably performed using a dispersing method such as ultrasonication. The preservation buffer solution may be, for example, a solution prepared by adding a predetermined concentration of an anti-aggregating agent and / or stabilizer to a washing buffer solution. Anti-aggregating agents include, for example, sugars such as sucrose, maltose, lactose, and trehalose, and polyhydric alcohols such as glycerin and polyvinyl alcohol. Stabilizers include, but are not limited to, proteins such as bovine serum albumin, ovalbumin, casein, and gelatin. In this manner, the preservation treatment of the labeled antibody 150 can be performed.

[0104] In each of the above steps, a surfactant or a preservative such as sodium azide or parahydroxybenzoic acid ester may be further used as needed.

[0105] [Analyte Measurement Kit] An analyte measurement kit according to one embodiment of the present invention is a kit for detecting or quantifying an analyte 160 contained in a sample, for example, using a test strip 200, based on the analyte measurement method of this embodiment.

[0106] The analyte measurement kit of this embodiment includes: a membrane 110; a test strip 200 including a determination section 130 in which a capture ligand 131 that specifically binds to the analyte 160 is immobilized on the membrane 110; and a detection reagent including a labeled antibody 150 in which an antibody that specifically binds to the analyte 160 is labeled with a labeling substance comprising a metal-resin composite 100. The analyte measurement kit of this embodiment may further include other components as necessary. For example, the analyte measurement kit may include a measuring device that measures the color intensity in the determination section 130. The analyte measurement kit may also include reference standard data such as a calibration curve, table, or formula showing the relationship between color intensity and analyte concentration.

[0107] When using the analyte measurement kit according to this embodiment, step (I) may be performed by contacting analyte 160 in a sample with labeled antibody 150 in a detection reagent, and then steps (II), (III), and (IV) may be performed sequentially by providing the sample to the reaction zone or sample addition zone 120 of test strip 200. Alternatively, a detection reagent may be applied upstream of determination zone 130 of test strip 200 and dried appropriately to form a reaction zone, and then a sample may be added to the formed reaction zone or to a position upstream of the reaction zone (e.g., sample addition zone 120), and steps (I) to (IV) may be performed sequentially.

[0108] Next, the present invention will be described in detail with reference to examples, but the present invention is not limited to these examples. In the following examples and comparative examples, various measurements and evaluations were carried out as follows, unless otherwise specified.

[0109] <Absorbance Measurement of Platinum-Resin Composite Particles> The absorbance of the platinum-resin composite particles was measured by placing a platinum-resin composite particle dispersion (dispersion medium: water) prepared at 0.01 wt % (weight %) in a quartz glass cell (light path length 10 mm) and measuring the absorbance at 400 nm using a spectrophotometer (UV3600, manufactured by Shimadzu Corporation). <Absorbance Measurement of Gold-Resin Composite Particles> The absorbance of the gold-resin composite particles was measured by placing a gold-resin composite particle dispersion (dispersion medium: water) prepared at 0.01 wt % (weight %) in a quartz glass cell (light path length 10 mm) and measuring the absorbance at 570 nm using a spectrophotometer (UV3600, manufactured by Shimadzu Corporation).

[0110] <Measurement of solid content concentration and measurement of metal loading amount> 1 g of the dispersion of metal-resin composite particles before concentration adjustment was placed in a porcelain crucible and dried at 70°C for 3 hours. The weights were measured before and after drying, and the solid content concentration was calculated using the following formula: Solid content concentration (wt%) = [Weight after drying (g) / Weight before drying (g)] x 100 Furthermore, the sample after the above drying treatment was further heat-treated at 500°C for 3 hours, the weights before and after the heat treatment were measured, and the metal loading amount was calculated using the following formula: Metal loading amount (wt%) = [Weight after heat treatment (g) / Weight before heat treatment (g)] x 100

[0111] <Measurement of Average Particle Diameter of Metal Particles> A substrate was prepared by dropping a metal-resin composite particle dispersion onto a metallic mesh with a carbon support film, and the area-average diameter of 100 random metal particles was measured from an image observed using a field emission scanning electron microscope (FE-SEM; Hitachi High-Technologies Corporation, SU-9000), and this was used as the average particle diameter.

[0112] <Measurement of average particle diameter of resin particles and metal-resin composite particles, calculation of CV value and mode> Measurement was performed using a centrifugal sedimentation particle size distribution analyzer (LUMiSizer 610, manufactured by LUM GmbH). The measurement was performed with the particles dispersed in water or a solution. The coefficient of variation (CV value) was calculated from the measured average particle diameter and standard deviation using the following formula: CV value (%) = standard deviation (nm) / average particle diameter (nm) × 100

[0113] [Preparation Example 1] <Synthesis of Resin Particles> A 500 ml round vessel was used, and an incomplete semicircular stirring blade was attached so that its longitudinal direction was perpendicular to the central axis of the round vessel. 300 g of pure water, an 80 wt % aqueous solution of trioctylmethylammonium chloride (1.55 g, 3.07 mmol), and a 50 wt % aqueous solution of polyethylene glycol methyl ether methacrylate (10.00 g, 2.40 mmol) were placed in the round vessel and dissolved. Next, 2-vinylpyridine (48.00 g, 457 mmol) and divinylbenzene (2.00 g, 15.4 mmol) were added, and the mixture was stirred at 100-200 rpm under a nitrogen stream at 30°C for 50 minutes, then at 60°C for 30 minutes. After stirring, 2,2-azobis(2-methylpropionamidine) dihydrochloride (0.250 g, 0.922 mmol) dissolved in 18.00 g of pure water was added dropwise, and the mixture was stirred at 60°C for 3 hours at a speed of 100 to 200 rpm to obtain resin particles A-1. After precipitation by centrifugation and removal of the supernatant, the mixture was redispersed in pure water and then filtered to remove impurities. The concentration was then adjusted to obtain a 10 wt % resin particle dispersion B-1. The average particle diameter of the resin particles A-1 in the resin particle dispersion B-1 was 395 nm, and the CV value was 1.44%.

[0114] [Preparation Example 2] <Synthesis of Resin Particles> A 500 ml round vessel was used, and an incomplete semicircular stirring blade was attached so that its longitudinal direction was perpendicular to the central axis of the round vessel. 300 g of pure water, an 80 wt % aqueous solution of trioctylmethylammonium chloride (1.76 g, 3.48 mmol), and a 50 wt % aqueous solution of polyethylene glycol methyl ether methacrylate (10.00 g, 2.40 mmol) were placed in the round vessel and dissolved. Next, 2-vinylpyridine (48.00 g, 457 mmol) and divinylbenzene (2.00 g, 15.4 mmol) were added, and the mixture was stirred at 100-200 rpm under a nitrogen stream at 30°C for 50 minutes, then at 60°C for 30 minutes. After stirring, 2,2-azobis(2-methylpropionamidine) dihydrochloride (0.250 g, 0.922 mmol) dissolved in 18.00 g of pure water was added dropwise, and the mixture was stirred at 60°C for 3 hours at a speed of 100 to 200 rpm to obtain resin particles A-2. After precipitation by centrifugation and removal of the supernatant, the mixture was redispersed in pure water and then filtered to remove impurities. The concentration was then adjusted to obtain a 10 wt % resin particle dispersion B-2. The average particle diameter of the resin particles A-2 in the resin particle dispersion B-2 was 328 nm, and the CV value was 2.23%.

[0115] [Preparation Example 3] <Synthesis of platinum-resin composite particles> 83.5 g of pure water was added to B-1 (30.00 g) obtained in Preparation Example 1, and then a 7 wt % aqueous solution of chloroplatinic acid (31.5 g) was added and stirred at 30°C and 100 to 200 rpm for 3 hours. This mixture was centrifuged, and the supernatant was removed to remove excess chloroplatinic acid. The concentration was then adjusted to obtain a 5 wt % platinum ion-adsorbing resin particle dispersion C-1.

[0116] Next, C-1 (70.45 g) diluted with 34.2 g of pure water was added to 4725 g of pure water while stirring at 0 to 3 ° C and a speed of 100 to 200 rpm. Furthermore, while stirring at 0 to 3 ° C and a speed of 100 to 200 rpm, 132 mM dimethylamine borane aqueous solution (138 g) was added dropwise over 20 minutes. Thereafter, by stirring at 0 to 3 ° C and a speed of 100 to 200 rpm for 60 minutes and at 25 to 28 ° C and a speed of 100 to 200 rpm for 2 hours, platinum-resin composite particles D-1 with an average particle size of 438 nm were obtained. The CV value of the particle size in D-1 was 1.4%. After concentrating D-1, it was purified by dialysis and the concentration was adjusted to obtain a 1 wt% platinum-resin composite particle dispersion E-1. The absorbance of platinum-resin composite particles F-1 in E-1 was 1.77. Furthermore, the average particle size of the platinum particles in F-1 was 3 nm, the standard deviation of the platinum particle size was 0.9 nm, and the platinum loading was 39.9 wt%. In these platinum-resin composite particles F-1, the platinum particles included encapsulated platinum particles that were completely encapsulated in the resin particles, and partially exposed platinum particles that had portions embedded in the resin particles and portions exposed outside the resin particles, and at least some of the platinum particles were distributed three-dimensionally in the surface layer of the resin particles. As a result of measuring the particle size distribution of the obtained E-1, the mode α of the particle size was 438.1 nm, and the proportion of particles smaller than the particle size α × 0.94 was 1.0%.

[0117] [Preparation Example 4] <Synthesis of Platinum-Resin Composite Particles> A 5 ​​wt % platinum ion-adsorbing resin particle dispersion C-2 was obtained in the same manner as in Preparation Example 3, except that B-2 obtained in Preparation Example 2 was used instead of B-1. Subsequently, platinum-resin composite particles D-2 having an average particle diameter of 368 nm were obtained in the same manner as in Preparation Example 3. The CV value of the particle diameter in D-2 was 1.4%. D-2 was concentrated and then purified by dialysis treatment, and the concentration was adjusted to obtain a 1 wt % platinum-resin composite particle dispersion E-2. The absorbance of platinum-resin composite particles F-2 in E-2 was 1.64. Furthermore, the average particle diameter of the platinum particles in F-2 was 3 nm, the standard deviation of the particle diameter of the platinum particles was 0.9 nm, and the platinum loading was 37.5 wt %. In the platinum-resin composite particles F-2, the platinum particles included encapsulated platinum particles that were completely encapsulated in the resin particles and partially exposed platinum particles that had portions embedded in the resin particles and portions exposed outside the resin particles, and at least some of the platinum particles were three-dimensionally distributed in the surface layer portions of the resin particles. As a result of measuring the particle size distribution of the obtained E-2, the mode α of the particle size was 368.0 nm, and the proportion of particles smaller than the particle size α × 0.94 was 2.0%.

[0118] Preparation Example 5 Synthesis of Gold-Resin Composite Particles 75.00 g of pure water was added to 30.00 g of B-2 obtained in Preparation Example 2, followed by 42.9 g of a 7 wt % aqueous solution of chloroauric acid. The mixture was then stirred at 100-200 rpm at 30°C for 3 hours. The resulting mixture was centrifuged, and the supernatant was removed to remove excess chloroauric acid. The concentration was then adjusted to obtain a 5 wt % dispersion of gold ion-adsorbing resin particles, C-3.

[0119] Next, C-3 (65.01 g) diluted with 30.0 g of pure water was added to 4725 g of pure water while stirring at 100-200 rpm at 0-3°C. Furthermore, while stirring at 100-200 rpm at 0-3°C, 528 mM dimethylamine borane aqueous solution (15.5 g) was added dropwise over 53 seconds. The mixture was then stirred at 100-200 rpm at 0-3°C for 60 minutes and at 100-200 rpm at 25-28°C for 2 hours, yielding gold-resin composite particles D-3 with an average particle size of 342 nm. The CV value of the particle size in D-3 was 1.9%. D-3 was concentrated, purified by dialysis, and the concentration was adjusted to obtain a 1 wt% gold-resin composite particle dispersion E-3. The absorbance of gold-resin composite particles F-3 in E-3 was 1.36. Furthermore, the average particle size of the gold particles in F-3 was 19.2 nm, the standard deviation of the gold particle size was 31.1 nm, and the gold loading was 48.3 wt %. In these gold-resin composite particles F-3, the gold particles included encapsulated gold particles that were completely encapsulated in the resin particles and partially exposed gold particles that had portions embedded in the resin particles and portions exposed outside the resin particles, and at least some of the gold particles were distributed three-dimensionally in the surface layer of the resin particles. Measurement of the particle size distribution of the resulting E-3 revealed that the mode α of the particle size was 342.0 nm, and the proportion of particles smaller than α × 0.94 was 2.0%.

[0120] [Preparation Example 6] <Synthesis of Resin Particles> A 500 ml round vessel was used, and an incomplete semicircular stirring blade was attached so that its longitudinal direction was perpendicular to the central axis of the round vessel. 300 g of pure water, an 80 wt % aqueous solution of trioctylmethylammonium chloride (1.55 g, 3.07 mmol), and a 50 wt % aqueous solution of polyethylene glycol methyl ether methacrylate (10.00 g, 2.40 mmol) were placed in the round vessel and dissolved. Next, 2-vinylpyridine (48.00 g, 457 mmol) and divinylbenzene (2.00 g, 15.4 mmol) were added, and the mixture was stirred at 20 rpm under a nitrogen stream at 30°C for 50 minutes, then at 60°C for 30 minutes. After stirring, 2,2-azobis(2-methylpropionamidine) dihydrochloride (0.250 g, 0.922 mmol) dissolved in 18.00 g of pure water was added dropwise, and the mixture was stirred at 20 rpm for 3 hours at 60°C to obtain resin particles A-3. After precipitation by centrifugation and removal of the supernatant, the mixture was redispersed in pure water and then filtered to remove impurities. The concentration was then adjusted to obtain a 10 wt % resin particle dispersion B-3. The average particle diameter of the resin particles A-3 in the resin particle dispersion B-3 was 385 nm, and the CV value was 17.2%.

[0121] [Preparation Example 7] <Synthesis of Platinum-Resin Composite Particles> A 5 ​​wt % platinum ion-adsorbing resin particle dispersion C-4 was obtained in the same manner as in Preparation Example 3, except that B-3 obtained in Preparation Example 6 was used instead of B-1. Subsequently, platinum-resin composite particles D-4 having an average particle diameter of 410 nm were obtained in the same manner as in Preparation Example 3. The CV value of the particle diameter in D-4 was 18.6%. D-4 was concentrated and then purified by dialysis treatment, and the concentration was adjusted to obtain a 1 wt % platinum-resin composite particle dispersion E-4. The absorbance of platinum-resin composite particles F-4 in E-4 was 1.75. Furthermore, the average particle diameter of the platinum particles in F-4 was 3 nm, the standard deviation of the particle diameter of the platinum particles was 0.9 nm, and the platinum loading was 38.5 wt %. In this platinum-resin composite F-4, the platinum particles included encapsulated platinum particles that were completely encapsulated in the resin particles and partially exposed platinum particles that had portions embedded in the resin particles and portions exposed outside the resin particles, and at least some of the platinum particles were three-dimensionally distributed in the surface layer portions of the resin particles. As a result of measuring the particle size distribution of the obtained E-4, the mode α of the particle size was 438.0 nm, and the proportion of particles smaller than the particle size α × 0.94 was 42.0%.

[0122] Example 1 (Antibody binding step) 25 μg of anti-CRP antibody was mixed with 0.45 mL of 50 mM HEPES buffer (pH 7), and then 0.05 mL of 1 wt % platinum-resin composite particle dispersion E-1 was added. The mixture was stirred by end-over-end at room temperature for 1 hour to obtain labeled antibody dispersion G-1 containing anti-CRP antibody labeled with platinum-resin composite particles F-1.

[0123] Next, the labeled antibody dispersion G-1 was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed. 0.5 mL of HEPES buffer (pH 7) containing 1 wt% sodium caseinate was added to the precipitated sediment, followed by ultrasonic dispersion and further end-over-end stirring at room temperature for 1 hour to obtain labeled antibody dispersion H-1.

[0124] (Washing Treatment) Next, the labeled antibody dispersion H-1 was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed. Thereafter, 0.5 mL of a 5 mM Tris aqueous solution (pH 8.5) containing less than 0.1 wt % of a surfactant was added to the sediment, followed by ultrasonic dispersion. This procedure was repeated three times to obtain labeled antibody dispersion I-1.

[0125] (Preparation of Conjugate Pad) Labeled antibody dispersion I-1 was centrifuged at 3,000 rpm for 5 minutes, and the supernatant was removed. Subsequently, a 5 mM Tris aqueous solution (pH 8.5) containing 5 wt % sucrose and 2.5 wt % BSA was added to the sediment, followed by ultrasonic dispersion to obtain labeled antibody dispersion J-1. A glass fiber nonwoven fabric was uniformly impregnated with labeled antibody dispersion J-1 and then dried at 50°C for 1 hour to prepare conjugate pad K-1. The concentration of labeled antibody dispersion J-1 and the amount applied to the glass fiber nonwoven fabric were adjusted so that the content of platinum-resin composite particles F-1 in conjugate pad K-1 was 3 μg per evaluation test by the immunochromatography method described below.

[0126] (Preparation of Immunochromatographic Strip) An immunochromatographic strip having the structure shown in Figure 4 was prepared. First, an anti-CRP antibody was applied to a 25 mm wide nitrocellulose membrane 4 to draw a test line 5. In addition, an anti-mouse IgG antibody was applied downstream of the test line 5 to draw a control line 6. This nitrocellulose membrane 4 was dried at 50°C for 1 hour, and then laminated with a laminate film 1, a conjugate pad K-1 as a conjugate pad 3, a sample pad 2 (glass fiber nonwoven fabric), and an absorbent pad 7 (cotton nonwoven fabric) as shown in the cross-sectional view of the immunochromatographic strip in Figure 4. Finally, the membrane was cut to a width of 3.5 mm to prepare an immunochromatographic strip L-1.

[0127] (Preparation of Developing Solution) An aqueous solution (pH 7.5) containing 50 mM Tris, 150 mM NaCl, 1.0 wt % BSA, and 1.0 wt % surfactant Triton X-100 was prepared and designated developing solution 1.

[0128] (Evaluation by immunochromatography) Positive control (antigen concentrations: 78.0, 39.0, 19.5, 9.8, 4.9, 2.4, 1.2, 0.6, 0.3 ng / ml) and negative control (antigen-free) sample solutions were prepared by diluting the CRP antigen with developing solution 1. 50 μl of the sample solution was dropped onto sample pad 2 of the Immunochromato Strip L-1. After 10 minutes, the color intensity of test line 5 was measured using an Immunochromato Reader (Hamamatsu Photonics C10066-10). The results of the immunochromatographic evaluation are shown in Table 1. The slope of the test line color intensity versus antigen concentration in the low concentration range of 5 ng / mL or less was 5.7, and the correlation coefficient was 0.986.

[0129] Example 2 The antibody binding step, blocking step, washing treatment, conjugate pad preparation, immunochromatographic strip preparation, and immunochromatographic evaluation were carried out in the same manner as in Example 1, except that 1 wt % platinum-resin composite particle dispersion E-2 was used instead of 1 wt % platinum-resin composite particle dispersion E-1. The results of the immunochromatographic evaluation are shown in Table 1. The slope of the test line color intensity versus antigen concentration in the low-concentration range of 5 ng / mL or less antigen concentration was 5.0, and the correlation coefficient was 0.989.

[0130] Example 3 The antibody binding step, blocking step, washing treatment, conjugate pad preparation, immunochromatographic strip preparation, and immunochromatographic evaluation were carried out in the same manner as in Example 1, except that 1 wt % gold-resin composite particle dispersion E-3 was used instead of 1 wt % platinum-resin composite particle dispersion E-1. The results of the immunochromatographic evaluation are shown in Table 1. The slope of the test line color intensity versus antigen concentration in the low-concentration range of 5 ng / mL or less antigen concentration was 10.2, and the correlation coefficient was 0.989.

[0131] Comparative Example 1 The antibody binding step, blocking step, washing treatment, conjugate pad preparation, immunochromatographic strip preparation, and immunochromatographic evaluation were carried out in the same manner as in Example 1, except that gold colloids (Tanaka Kikinzoku Kogyo, Au colloid solution-SC, particle size 50 nm) were used as particles, 5 mM Tris aqueous solution (pH 9.5) was used as the binding buffer, and 5 mM Tris aqueous solution (pH 9.5) containing 1 wt % BSA was used as the blocking buffer. Table 1 shows the results of the evaluation by the immunochromatographic method. The slope of the test line color intensity versus antigen concentration in the low concentration range of 5 ng / mL or less was 1.0, and the correlation coefficient was 0.779.

[0132] As a result of measuring the particle size distribution of the gold colloid, the CV value of the particle size was 8.2%, the mode α of the particle size was 48.7 nm, and the proportion of particles smaller than α×0.94 was 17.0%.

[0133] Comparative Example 2 The antibody binding step, blocking step, washing treatment, conjugate pad preparation, immunochromatographic strip preparation, and immunochromatographic evaluation were carried out in the same manner as in Example 1, except that 1 wt % platinum-resin composite particle dispersion E-4 was used instead of 1 wt % platinum-resin composite particle dispersion E-1. The results of the immunochromatographic evaluation are shown in Table 1. The slope of the test line color intensity versus antigen concentration in the low-concentration range of 5 ng / mL or less antigen concentration was 2.4, and the correlation coefficient was 0.884.

[0134] Comparative Example 3 The antibody binding step, blocking step, washing step, conjugate pad preparation, immunochromatographic strip preparation, and immunochromatographic evaluation were carried out in the same manner as in Example 1, except that red latex (Merck Millipore, Estapor Red, K1 040D, particle size 400 nm) was used as the particles and a 50 mM MES aqueous solution (pH 6) was used as the binding buffer, and chemical binding treatment was carried out by the EDC-NHS coupling method. The immunochromatographic evaluation results are shown in Table 1. The slope of the test line color intensity versus antigen concentration in the low concentration range of 5 ng / mL or less was 1.1, and the correlation coefficient was 0.779.

[0135] As a result of measuring particle size distribution of the red latex, the CV value of the particle size was 20.3%, the mode α of the particle size was 338.8 nm, and the existence ratio of particles smaller than the particle size α×0.94 was 18.0%.

[0136]

[0137] From the test results of Examples 1, 2, and 3 and Comparative Examples 1, 2, and 3 shown in Table 1, scatter plots (FIGS. 5A and 5B) of test line color intensity versus CRP antigen concentration were created to compare the sensitivity of immunochromatography. Furthermore, the particle size distribution measurement results of the particles used in Examples 1, 2, and 3 and Comparative Examples 1, 2, and 3, as well as the slope and correlation coefficient of the test line color intensity in the antigen concentration range of 0 to 5 ng / ml were calculated and are shown in Table 2.

[0138] As shown in Figure 5A, when metal-resin composite particles with a uniform particle size and a CV value of 2% or less were used (Examples 1, 2, and 3), the test line color intensity was approximately twice as high as when gold colloid or red latex was used (Comparative Examples 1 and 3), confirming that highly sensitive detection was possible. Furthermore, as shown in the scatter plot for the antigen concentration range of 0 to 5 ng / ml in Figure 5B and Table 2, in the low antigen concentration range, Examples 1, 2, and 3 had a steeper slope of the calibration curve of test line color intensity versus antigen concentration than Comparative Examples 1, 2, and 3, with a correlation coefficient closer to 1. From these results, it can be said that when metal-resin composite particles with a uniform particle size and a CV value of 2% or less were used, quantitative detection of antigen concentrations with higher sensitivity was possible, even at low antigen concentrations.

[0139]

[0140] Although the embodiments of the present invention have been described in detail above for the purpose of illustration, the present invention is not limited to the above-described embodiments.

[0141] This application claims priority based on Japanese Patent Application No. 2023-089651, filed on May 31, 2023, the entire contents of which are incorporated herein by reference.

[0142] 1...Laminate film, 2...Sample pad, 3...Conjugate pad, 4...Nitrocellulose membrane, 5...Test line, 6...Control line, 7...Absorption pad, 10...Resin particle, 20...Metal particle, 30...Encapsulated particle, 40...Partially exposed particle, 50...Surface-adsorbed particle, 60...Surface layer, 100...Metal-resin composite, 110...Membrane, 120...Sample addition section, 130...Determination section, 131...Capture ligand, 140...Liquid absorption section, 150...Labeled antibody, 160...Analyte, 170...Complex, 200...Test strip

Claims

1. A labeled substance comprising a metal-resin composite having resin particles and a plurality of metal particles fixed to the resin particles, characterized in that the CV value of the particle diameter of the metal-resin composite is 6% or less, and when the most frequent particle diameter of the metal-resin composite detected by a particle size distribution measuring device is α [nm], the proportion of particles having a particle diameter smaller than α x 0.94 is 10% or less.

2. The labeling substance according to claim 1, wherein the metal particles are particles of platinum or an alloy thereof, or particles of gold or an alloy thereof.

3. The labeling substance according to claim 1, wherein the average particle size of the metal-resin complex is within the range of 50 nm to 1000 nm.

4. The labeling substance according to claim 1, wherein at least a portion of the metal particles are three-dimensionally distributed in the surface layer of the resin particle.

5. The labeling substance according to claim 1, which is used by adsorbing an antigen or an antibody onto the surface of the metal-resin complex.

6. An immunological assay method using the labeling substance according to claim 1.

7. A reagent for immunoassay comprising the labeling substance according to claim 1.

8. A method for measuring an analyte contained in a sample, detecting or quantifying the analyte, comprising the following steps (I) to (III) using a lateral flow chromatography test strip including a membrane and a determination section in which a capture ligand that specifically binds to the analyte is immobilized on the membrane: step (I): contacting the analyte contained in the sample with a labeled antibody obtained by labeling an antibody that specifically binds to the analyte with the labeling substance described in claim 1; step (II): contacting the complex containing the analyte and the labeled antibody formed in step (I) with the capture ligand in the determination section; step (III): measuring the color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electron transition of a metal-resin complex in the labeling substance.

9. The method for measuring an analyte according to claim 8, further comprising step (IV): estimating the amount of the analyte contained in the sample based on the measured color intensity.

10. An analyte measurement kit for detecting or quantifying an analyte contained in a sample, comprising: a lateral flow type chromatography test strip including a membrane and a determination section in which a capture ligand that specifically binds to the analyte is fixed to the membrane; and a detection reagent including a labeled antibody in which an antibody that specifically binds to the analyte is labeled with the labeling substance described in claim 1.

11. The analyte measurement kit according to claim 10, further comprising a device for measuring the color intensity in the determination section, the color intensity being a color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electronic transition of the metal-resin complex in the complex of the analyte and the labeled antibody.

12. The analyte measurement kit according to claim 10, further comprising reference standard data showing the relationship between the color intensity in the determination area and the concentration of the analyte, the color intensity being a color intensity resulting from light energy absorption due to localized surface plasmon resonance and / or electronic transition of the metal-resin complex in the complex of the analyte and the labeled antibody.

13. A lateral flow chromatography test strip for detecting or quantifying an analyte contained in a sample, comprising: a membrane; a determination section in which a capture ligand that specifically binds to the analyte is fixed to the membrane in the direction in which the sample develops; and a reaction section upstream of the determination section, which contains a labeled antibody in which the antibody that specifically binds to the analyte is labeled with the labeling substance described in claim 1.

Citation Information

Patent Citations

  • Colored latex

    JP2009168495A

  • Analyte quantification

    JP2022502637A

  • Information extraction device, information extraction method and information extraction program

    JP2023089651A

  • Reverse IgE LFIA

    JP2023506679A

  • Device for integrated extraction, enrichment and detection of analytes - Patent Application 20070122999

    JP6833519B2